Open Access Mini Review

Cost of Biotech Drug Development and Affordability Issues in LMICs

Abdul Kader Mohiuddin*

Department of Pharmacy, World University of Bangladesh, Bangladesh

Corresponding Author

Received Date:July 16, 2019;  Published Date:July 29, 2019

Abstract

Pharmaceutical companies invest in the development and testing of their drugs including by funding clinical trials. Furthermore, pharmaceutical companies also spend a large amount of money on advertising. For instance, in 2016 US$6.7 billion was spent on direct-to-consumer pharmaceutical advertising alone in the USA [1]. Worldwide spending on medicines reached $1.2 trillion in 2018 and will exceed $1.5 trillion by 2023, according to “The Global Use of Medicine in 2019 and Outlook to 2023” [2,3].

Citation
Signup for Newsletter
Scroll to Top